Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc.
Maastricht University Medical Center
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.